DENISE MORALES: Open Payments
NPI 1255925509 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 56 payments from 11 companies in 2025. Trend: 2023 $557 · 2024 $230 · 2025 $1,002
Food & beverage: $890Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $264 |
| Vanda Pharmaceuticals Inc. | 18 | $257 |
| Lundbeck LLC | 11 | $174 |
| Otsuka America Pharmaceutical, Inc. | 1 | $70 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| Braeburn Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: FANAPT, REXULTI, AUSTEDO XR, UZEDY, BRIXADI, SPRAVATO, VRAYLAR, INGREZZA.
Industry payments across NM — which companies pay providers there.
